Genomic Confidence

Some oncologists are rather gung-ho about using multiplex genomic tests and ready to use them to evaluate tumors and develop treatments for most of their patients, but others are much more wary about these gadgets, a new study finds.

The survey results, published in the Journal of Clinical Oncology, suggests there is "wide variation" in attitudes among cancer doctors about using multiplex tests to hunt for hundreds of variations in tumors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.